Cipta Sarana Medika Tbk. vs Abadi Lestari Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Abadi Lestari Indonesia Tbk. trades at Rp3,260 (market cap 10.06T, 688.4K 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 63.6× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 688.4K). Which is the better fit depends on your goals.
| DKHH | RLCO | |
|---|---|---|
Market Cap | 158.12B | 10.06T |
Volume | 8.21M | 688.4K |
Lot | 82.15K | 6.88K |
Turnover | 515.2M | 2.25B |
Average Price | 62.72 | 3,273.17 |
Value | 515.2M | 2.25B |
Indicative Equilibrium Price | 63 | 3,260 |
Indicative Equilibrium Volume | 1.33K | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →